ASCOT Trial - Time to Benefit

Time to Benefit

In the ASCOT Trial, a primary prevention trial, there was very early separation between the placebo group and those on atorvastatin 10 mg OD - within weeks! It was ternimated 1.5 years earlier than planned because of a 36% cardiovascular event reduction demonstrated in just 3.5 years. The benefits of statin increases with duration of therapy.

New Jersey Preventive Cardiology & Cholesterol Clinic, PC    © 2005           To learn more, visit us at www.CholesterolClinic.com .              Disclaimer